Altimmune Financial Overview
Altimmune's market cap is currently $417.37M. The company's EPS TTM is $-0.21; its P/E ratio is -3.74; Altimmune is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
